FOSL2 promotes leptin gene expression in human and mouse adipocytes

Journal of Clinical Investigation

Volumn 122, Issue 3, 2012, Pages 1010-1021

  Wrann, Christiane D ^a   Eguchi, Jun ^a,f   Bozec, Aline ^b   Xu, Zhao ^a   Mikkelsen, Tarjei ^c   Gimble, Jeffrey ^d   Nave, Heike ^e   Wagner, Erwin F ^b   Ong, Shao En ^c   Rosen, Evan D ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Structural Biology and Biocomputing Programme   (Spain)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^f OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA PROTEIN COMPLEX; FOS LIKE ANTIGEN 2 GENE; GENE; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEOMICS; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CHROMATIN; CHROMOSOME MAPPING; FEMALE; FOS-RELATED ANTIGEN-2; GENE EXPRESSION PROFILING; GENES, REPORTER; GENOMICS; GREEN FLUORESCENT PROTEINS; HUMANS; LEPTIN; MICE; MICE, TRANSGENIC; MODELS, GENETIC; PROTEOMICS;

EID: 84863229577     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58431     Document Type: Article

References (64)

1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Sources of differences in estimates of obesity-associated deaths from first National Health and Nutrition Examination Survey (NHANES I) hazard ratios. Am J Clin Nutr. 2010;91(3):519-527.
2. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444(7121):847-853. (Pubitemid 46024991)
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-432. (Pubitemid 24365442)
4. Halaas JL, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543-546.
5. Belgardt BF, Brüning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci. 2010;1212:97-113.
6. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord. 2002;26(11):1407-1433. (Pubitemid 36007818)
7. Friedman JM. Leptin at 14 y of age: an ongoing story. Am J Clin Nutr. 2009;89(3):973S-979.
8. Ebihara K, et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab. 2007;92(2):532-541.
9. Heymsfield SB, et al. Recombinant leptin for weight loss in obese and lean adults. JAMA. 1999;282(16):1568-1575.
10. Ravussin E, et al. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring). 2009;17(9):1736-1743.
11. Goiot H, Laigneau JP, Devaud H, Sobhani I, Bado A. Similarities and differences in the transcriptional regulation of the leptin gene promoter in gastric and adipose cells. FEBS Lett. 2005;579(9):1911-1916. (Pubitemid 40404030)
12. Moreno-Aliaga MJ, Swarbrick MM, Lorente-Cebrian S, Stanhope KL, Havel PJ, Martinez JA. Sp1-mediated transcription is involved in the induction of leptin by insulin-stimulated glucose metabolism. J Mol Endocrinol. 2007;38(5):537-546. (Pubitemid 47019057)
13. Simopoulou T, et al. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage. 2007;15(8):872-883. (Pubitemid 47209251)
14. Kallen CB, Lazar MA. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A. 1996;93(12):5793-5796. (Pubitemid 26191315)
15. Harris RB, Ramsay TG, Smith SR, Bruch RC. Early and late stimulation of ob mRNA expression in meal-fed and overfed rats. J Clin Invest. 1996;97(9):2020-2026. (Pubitemid 26143955)
16. de la Brousse FC, Shan B, Chen JL. Identification of the promoter of the mouse obese gene. Proc Natl Acad Sci U S A. 1996;93(9):4096-4101. (Pubitemid 26144249)
17. Gong DW, Bi S, Pratley RE, Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem. 1996;271(8):3971-3974. (Pubitemid 26070491)
18. He Y, Chen H, Quon MJ, Reitman M. The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem. 1995;270(48):28887-28891.
19. Hwang CS, Mandrup S, MacDougald OA, Geiman DE, Lane MD. Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc Natl Acad Sci U S A. 1996;93(2):873-877. (Pubitemid 26041186)
20. Miller SG, et al. The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression. Proc Natl Acad Sci U S A. 1996;93(11):5507-5511. (Pubitemid 26159480)
21. Kim JB, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest. 1998;101(1):1-9. (Pubitemid 28058896)
22. Chen XL, Hartzell DL, McGraw RA, Hausman GJ, Dean RG. Analysis of a 762-bp proximal leptin promoter to drive and control regulation of transgene expression of growth hormone receptor in mice. Biochem Biophys Res Commun. 1999;262(1):187-192. (Pubitemid 29412645)
23. Heintzman ND, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature. 2009;459(7243):108-112.
24. Visel A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature. 2009;457(7231):854-858.
25. Hill F, Benes V, Thomasova D, Stewart AF, Kafatos FC, Ansorge W. BAC trimming: minimizing clone overlaps. Genomics. 2000;64(1):111-113. (Pubitemid 30165081)
26. MacDougald OA, Hwang CS, Fan H, Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci U S A. 1995;92(20):9034-9037.
27. Bernstein BE, et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol. 2010;28(10):1045-1048.
28. Creyghton MP, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A. 2010;107(50):21931-21936.
29. Owyang SY, Luther J, Kao JY. Helicobacter pylori: beneficial for most? Expert Rev Gastroenterol Hepatol. 2011;5(6):649-651.
30. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. Nat Rev Genet. 2009;10(4):252-263.
31. Ovcharenko I, et al. Mulan: multiple-sequence local alignment and visualization for studying function and evolution. Genome Res. 2005;15(1):184-194.
32. Ong SE, et al. Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci U S A. 2009;106(12):4617-4622.
33. Eferl R, Zenz R, Theussl HC, Wagner EF. Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Genesis. 2007;45(7):447-451. (Pubitemid 47221805)
34. Eferl R, et al. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A. 2008;105(30):10525-10530.
35. Fuke T, et al. Transcription factor AP-2beta inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes. Int J Obes (Lond). 2010;34(4):670-678.
36. Melzner I, et al. Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem. 2002;277(47):45420-45427. (Pubitemid 36159150)
37. Stachowiak M, et al. Polymorphism of the porcine leptin gene promoter and analysis of its association with gene expression and fatness traits. Biochem Genet. 2007;45(3-4):245-253. (Pubitemid 46466214)
38. Liu D, Hu Y, Yang X, Liu Y, Wei S, Jiang Y. Identification and genetic effects of a novel polymorphism in the distal promoter region of porcine leptin gene. Mol Biol Rep. 2011;38(3):2051-2057.
39. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3(11):859-868. (Pubitemid 37383716)
40. Foletta VC, Sonobe MH, Suzuki T, Endo T, Iba H, Cohen DR. Cloning and characterisation of the mouse fra-2 gene. Oncogene. 1994;9(11):3305-3311. (Pubitemid 24338459)
41. Carrasco D, Bravo R. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development. Oncogene. 1995;10(6):1069-1079.
42. Bozec A, Bakiri L, Jimenez M, Schinke T, Amling M, Wagner EF. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J Cell Biol. 2010;190(6):1093-1106.
43. Bozec A, et al. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature. 2008;454(7201):221-225. (Pubitemid 351969891)
44. Karreth F, Hoebertz A, Scheuch H, Eferl R, Wagner EF. The AP1 transcription factor Fra2 is required for efficient cartilage development. Development. 2004;131(22):5717-5725. (Pubitemid 39625214)
45. Stephens JM, Butts MD, Pekala PH. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. J Mol Endocrinol. 1992;9(1):61-72.
46. Distel RJ, Ro HS, Rosen BS, Groves DL, Spiegelman BM. Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos. Cell. 1987;49(6):835-844.
47. Sabatakos G, et al. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 2000;6(9):985-990.
48. Rowe GC, Choi CS, Neff L, Horne WC, Shulman GI, Baron R. Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology. 2009;150(1):135-143.
49. Luther J, et al. Elevated Fra-1 expression causes severe lipodystrophy. J Cell Sci. 2011;124(pt 9):1465-1476.
50. Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene. 2001;20(19):2438-2452. (Pubitemid 32531301)
51. Murakami M, Ui M, Iba H. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. Cell Growth Differ. 1999;10(5):333-342. (Pubitemid 29242599)
52. Sexton T, Bantignies F, Cavalli G. Genomic interactions: chromatin loops and gene meeting points in transcriptional regulation. Semin Cell Dev Biol. 2009;20(7):849-855.
53. Todorcevic M, Skugor S, Krasnov A, Ruyter B. Gene expression profiles in Atlantic salmon adiposederived stromo-vascular fraction during differentiation into adipocytes. BMC Genomics. 2010;11:39.
54. Sanchez C, Oskowitz A, Pochampally RR. Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells. Stem Cells. 2009;27(2):375-382.
55. Halberg N, et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009;29(16):4467- 4483.
56. Grosfeld A, Zilberfarb V, Turban S, Andre J, Guerre-Millo M, Issad T. Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia. 2002;45(4):527-530. (Pubitemid 34533831)
57. Lolmede K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumie A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord. 2003;27(10):1187-1195. (Pubitemid 37281666)
58. Wang B, Wood IS, Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol. 2008;198(1):127-134. (Pubitemid 352038192)
59. Ambrosini G, Nath AK, Sierra-Honigmann MR, Flores-Riveros J. Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem. 2002;277(37):34601- 34609.
60. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem. 2002;277(45):42953-42957. (Pubitemid 35285673)
61. Cascio S, et al. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. Oncogene. 2008;27(4):540-547.
62. Testa G, et al. Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles. Nat Biotechnol. 2003;21(4):443-447. (Pubitemid 36397667)
63. Copeland NG, Jenkins NA, Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet. 2001;2(10):769-779. (Pubitemid 33685574)
64. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101-1108. (Pubitemid 351818697)